Cargando…
Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI
BACKGROUND: Several randomized controlled trials (RCT) have reported no difference in long-term mortality between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). The purpose of this pooled observational analysis was to compare recent retrospective studies examini...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942885/ https://www.ncbi.nlm.nih.gov/pubmed/24611133 |
_version_ | 1782479132997713920 |
---|---|
author | Efird, Jimmy T. O’Neal, Wesley T. Davies, Stephen W. Kennedy, Whitney L. Alger, Lada N. O’Neal, Jason B. Ferguson, T. Bruce Kypson, Alan P. |
author_facet | Efird, Jimmy T. O’Neal, Wesley T. Davies, Stephen W. Kennedy, Whitney L. Alger, Lada N. O’Neal, Jason B. Ferguson, T. Bruce Kypson, Alan P. |
author_sort | Efird, Jimmy T. |
collection | PubMed |
description | BACKGROUND: Several randomized controlled trials (RCT) have reported no difference in long-term mortality between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). The purpose of this pooled observational analysis was to compare recent retrospective studies examining long-term survival of patients with multi-vessel coronary artery disease undergoing CABG and PCI. METHODOLOGY: We searched Medline for observational studies comparing long-term (>1 year) survival between CABG and PCI for the treatment of multi-vessel coronary artery disease over the past 10 years. RESULTS: Eight studies met inclusion criteria. A total of 306,868 patients (155,502 CABG; 151,366 PCI) were identified. Follow-up ranged from 1 to 8 years. Mantel-Haenszel combined hazard ratios (HR) for mortality demonstrated a protective benefit of CABG compared with PCI (HR=0.77, 95%CI=0.75–0.79). CONCLUSION: These findings suggest a long-term survival advantage for CABG compared with PCI in patients with multi-vessel coronary artery disease. |
format | Online Article Text |
id | pubmed-3942885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-39428852014-03-05 Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI Efird, Jimmy T. O’Neal, Wesley T. Davies, Stephen W. Kennedy, Whitney L. Alger, Lada N. O’Neal, Jason B. Ferguson, T. Bruce Kypson, Alan P. Br J Med Med Res Article BACKGROUND: Several randomized controlled trials (RCT) have reported no difference in long-term mortality between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). The purpose of this pooled observational analysis was to compare recent retrospective studies examining long-term survival of patients with multi-vessel coronary artery disease undergoing CABG and PCI. METHODOLOGY: We searched Medline for observational studies comparing long-term (>1 year) survival between CABG and PCI for the treatment of multi-vessel coronary artery disease over the past 10 years. RESULTS: Eight studies met inclusion criteria. A total of 306,868 patients (155,502 CABG; 151,366 PCI) were identified. Follow-up ranged from 1 to 8 years. Mantel-Haenszel combined hazard ratios (HR) for mortality demonstrated a protective benefit of CABG compared with PCI (HR=0.77, 95%CI=0.75–0.79). CONCLUSION: These findings suggest a long-term survival advantage for CABG compared with PCI in patients with multi-vessel coronary artery disease. 2013-04-02 2013 /pmc/articles/PMC3942885/ /pubmed/24611133 Text en © 2013 Efirdet al. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Efird, Jimmy T. O’Neal, Wesley T. Davies, Stephen W. Kennedy, Whitney L. Alger, Lada N. O’Neal, Jason B. Ferguson, T. Bruce Kypson, Alan P. Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI |
title | Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI |
title_full | Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI |
title_fullStr | Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI |
title_full_unstemmed | Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI |
title_short | Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI |
title_sort | long-term mortality of 306,868 patients with multi-vessel coronary artery disease: cabg versus pci |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942885/ https://www.ncbi.nlm.nih.gov/pubmed/24611133 |
work_keys_str_mv | AT efirdjimmyt longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT onealwesleyt longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT daviesstephenw longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT kennedywhitneyl longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT algerladan longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT onealjasonb longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT fergusontbruce longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci AT kypsonalanp longtermmortalityof306868patientswithmultivesselcoronaryarterydiseasecabgversuspci |